IDEAYA Biosciences Inc. (IDYA)
IDEAYA Biosciences Statistics
Share Statistics
IDEAYA Biosciences has 87.54M shares outstanding. The number of shares has increased by 15.66% in one year.
| Shares Outstanding | 87.54M |
| Shares Change (YoY) | 15.66% |
| Shares Change (QoQ) | 1.28% |
| Owned by Institutions (%) | 99.99% |
| Shares Floating | 80.84M |
| Failed to Deliver (FTD) Shares | 12 |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 10.67M, so 12.19% of the outstanding shares have been sold short.
| Short Interest | 10.67M |
| Short % of Shares Out | 12.19% |
| Short % of Float | 13.57% |
| Short Ratio (days to cover) | 5.21 |
Valuation Ratios
The PE ratio is -7.65 and the forward PE ratio is -7.1. IDEAYA Biosciences's PEG ratio is -0.11.
| PE Ratio | -7.65 |
| Forward PE | -7.1 |
| PS Ratio | 299.88 |
| Forward PS | 2.7 |
| PB Ratio | 1.98 |
| P/FCF Ratio | -8.35 |
| PEG Ratio | -0.11 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for IDEAYA Biosciences.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 14.97, with a Debt / Equity ratio of 0.02.
| Current Ratio | 14.97 |
| Quick Ratio | 14.97 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | -0.06 |
| Debt / FCF | -0.08 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $53.44K |
| Profits Per Employee | $-2.1M |
| Employee Count | 131 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -51.04% in the last 52 weeks. The beta is 0.51, so IDEAYA Biosciences's price volatility has been higher than the market average.
| Beta | 0.51 |
| 52-Week Price Change | -51.04% |
| 50-Day Moving Average | 18.25 |
| 200-Day Moving Average | 27.72 |
| Relative Strength Index (RSI) | 64.96 |
| Average Volume (20 Days) | 1.21M |
Income Statement
In the last 12 months, IDEAYA Biosciences had revenue of 7M and earned -274.48M in profits. Earnings per share was -3.36.
| Revenue | 7M |
| Gross Profit | 3.17M |
| Operating Income | -326.98M |
| Net Income | -274.48M |
| EBITDA | -326.98M |
| EBIT | -326.98M |
| Earnings Per Share (EPS) | -3.36 |
Balance Sheet
The company has 84.38M in cash and 19.17M in debt, giving a net cash position of 65.21M.
| Cash & Cash Equivalents | 84.38M |
| Total Debt | 19.17M |
| Net Cash | 65.21M |
| Retained Earnings | -622.84M |
| Total Assets | 1.12B |
| Working Capital | 643.64M |
Cash Flow
In the last 12 months, operating cash flow was -247.58M and capital expenditures -3.86M, giving a free cash flow of -251.44M.
| Operating Cash Flow | -247.58M |
| Capital Expenditures | -3.86M |
| Free Cash Flow | -251.44M |
| FCF Per Share | -3.08 |
Margins
Gross margin is 45.23%, with operating and profit margins of -4671.07% and -3921.1%.
| Gross Margin | 45.23% |
| Operating Margin | -4671.07% |
| Pretax Margin | -3921.1% |
| Profit Margin | -3921.1% |
| EBITDA Margin | -4671.07% |
| EBIT Margin | -4671.07% |
| FCF Margin | -3592.01% |
Dividends & Yields
IDYA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for IDYA is $53, which is 162.9% higher than the current price. The consensus rating is "Buy".
| Price Target | $53 |
| Price Target Difference | 162.9% |
| Analyst Consensus | Buy |
| Analyst Count | 13 |
Scores
| Altman Z-Score | 14.92 |
| Piotroski F-Score | 2 |